Alan G. Ramsay

7.0k total citations · 1 hit paper
112 papers, 4.9k citations indexed

About

Alan G. Ramsay is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Alan G. Ramsay has authored 112 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 44 papers in Pathology and Forensic Medicine and 40 papers in Genetics. Recurrent topics in Alan G. Ramsay's work include Lymphoma Diagnosis and Treatment (42 papers), Chronic Lymphocytic Leukemia Research (40 papers) and CAR-T cell therapy research (27 papers). Alan G. Ramsay is often cited by papers focused on Lymphoma Diagnosis and Treatment (42 papers), Chronic Lymphocytic Leukemia Research (40 papers) and CAR-T cell therapy research (27 papers). Alan G. Ramsay collaborates with scholars based in United Kingdom, United States and Italy. Alan G. Ramsay's co-authors include John G. Gribben, Rewas Fatah, Andrew Clear, John C. Riches, Abigail M. Lee, Rifca Le Dieu, John F. Marshall, Güllü Görgün, John C. Byrd and Amy J. Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Alan G. Ramsay

107 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

2013 441 citations Andrew Clear, John C. Riches et al. profile →

Peers

Countries citing papers authored by Alan G. Ramsay

Since Specialization

Citations

This map shows the geographic impact of Alan G. Ramsay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Ramsay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Ramsay more than expected).

Fields of papers citing papers by Alan G. Ramsay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Ramsay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Ramsay. The network helps show where Alan G. Ramsay may publish in the future.

Co-authorship network of co-authors of Alan G. Ramsay

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Ramsay. A scholar is included among the top collaborators of Alan G. Ramsay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Ramsay. Alan G. Ramsay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The phenogenomic landscapes of pleural mesothelioma tumor microenvironment predict clinical outcomes 2025 ·Journal of Translational Medicine ·Federica Torricelli, Filomena Spada, Cynthia Bishop, (unknown), Daisuke Nonaka, Nedyalko Petrov, Manuela Terranova Barberio, Alan G. Ramsay, Richard J. Ellis, Alessia Ciarrocchi, Benedetta Apollonio, Andrea Billè	0
2	Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial 2024 ·BMC Cancer ·Graham McIlroy, Siân Lax, Charlotte Gaskell, Aimee Jackson, (unknown), (unknown), Sonia Fox, (unknown), Jessica Okosun, Sally F. Barrington, Ingo Ringshausen, Alan G. Ramsay, Maria Calaminici, Kim Linton, Mark Bishton	1
3	Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial 2023 ·Blood ·(unknown), Victoria Wang, Tait D. Shanafelt, Connie Lesnick, Nikolaos Ioannou, Giulia De Rossi, Sylvia Herter, Marina Bacac, Christian Klein, Martin S. Tallman, Neil E. Kay, Alan G. Ramsay	10
4	Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures 2022 ·Leukemia ·(unknown), Nikolaos Ioannou, Mariela Sivina, (unknown), Karen Clise-Dwyer, Ekaterina Kim, Dan Li, Qing Ma, Alessandra Ferrajoli, Zeev Estrov, William G. Wierda, Piers Patten, Alan G. Ramsay, Jan A. Burger	12
5	ImmunoCluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data 2021 ·eLife ·James W. Opzoomer, (unknown), Kevin Blighe, Thanos P. Mourikis, Nicolas Chapuis, (unknown), (unknown), (unknown), Benedetta Apollonio, Alan G. Ramsay, Mahvash Tavassoli, Claire Harrison, Francesca D. Ciccarelli, Peter J. Parker, Michaëla Fontenay, Paul R. Barber, James N. Arnold, Shahram Kordasti	10
6	T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities 2020 ·Clinical Cancer Research ·Anna Vardi, (unknown), (unknown), Fotis Psomopoulos, (unknown), Nikolaos Ioannou, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Niki Stavroyianni, Paolo Ghia, Αchilles Anagnostopoulos, Anastasia Kouvatsi, Alan G. Ramsay, Κώστας Σταματόπουλος, Anastasia Chatzidimitriou	20
7	Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type 2018 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Giuseppe Bello, Ayse U. Akarca, Maria Raffaella Ambrosio, Claudio Agostinelli, Hernan Molina‐Kirsch, Alan G. Ramsay, Manuel Rodriguez‐Justo, Matthew Pugh, Shuchun Zhao, (unknown), Elena Sabattini, Stefan Dojcinov, Stefano Pileri, Yasodha Natkunam, Lorenzo Leoncini, Teresa Marafioti	4
8	In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis 2016 ·PLoS Pathogens ·Lucy Bell, Gabriele Pollara, (unknown), Gillian S. Tomlinson, Rannakoe Lehloenya, Jennifer Roe, Richard Meldau, Robert F. Miller, Alan G. Ramsay, Benny Chain, Keertan Dheda, Mahdad Noursadeghi	35
9	Tumor microenvironment (TME)-driven immune suppression in B cell malignancy 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Nicole S. Nicholas, Benedetta Apollonio, Alan G. Ramsay	99
10	How does lenalidomide target the chronic lymphocytic leukemia microenvironment? 2014 ·Blood ·Arnon P. Kater, Sanne H. Tonino, Alexander Egle, Alan G. Ramsay	46
11	Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation 2013 ·Journal of Clinical Oncology ·Shahryar Kiaii, Andrew Clear, Alan G. Ramsay, Derek Davies, Ajanthah Sangaralingam, Abigail Lee, Maria Calaminici, Donna Neuberg, John G. Gribben	80
12	The Response of HIV-Associated Lymphadenopathic Kaposi Sarcoma to Highly Active Antiretroviral Therapy Evaluated by 18F-FDG PET/CT 2012 ·Clinical Nuclear Medicine ·(unknown), Robert F. Miller, Simon Edwards, Alan G. Ramsay, Siow Ming Lee	5
13	Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the¹⁸F-fluoro-2-deoxyglucose positron emission tomography era 2011 ·Leukemia & lymphoma ·Simon Richardson, (unknown), Victoria Warbey, Alan G. Ramsay, Christopher McNamara	32
14	Chronic Lymphocytic Leukemia: An Update on Biology and Treatment 2011 ·Current Oncology Reports ·John C. Riches, Alan G. Ramsay, John G. Gribben	13
15	Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment 2010 ·Blood ·Andrew Clear, Abigail M. Lee, Maria Calaminici, Alan G. Ramsay, Kelly J Morris, Simon Hallam, Gavin Kelly, Finlay MacDougall, Tim Lister, John G. Gribben	98
16	Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion 2010 ·Oncogene ·Mark R. Morgan, (unknown), Alan G. Ramsay, Gareth J. Thomas, Martin J. Boulanger, Ian R. Hart, John F. Marshall	28
17	HS1-Associated Protein X-1 Regulates Carcinoma Cell Migration and Invasion via Clathrin-Mediated Endocytosis of Integrin αvβ6 2007 ·Cancer Research ·Alan G. Ramsay, Matthias Epple, (unknown), Gareth J. Thomas, Maddy Parsons, Shelia M. Violette, Paul H. Weinreb, Ian R. Hart, John F. Marshall	111
18	Tyrosine phosphorylation in human lymphomas 2003 ·The Histochemical Journal ·Eugenia Haralambieva, Margaret T. Jones, Giovanna Roncador, Lorenzo Cerroni, Laurence Lamant, German Ott, Andreas Rosenwald, Christopher Sherman, Paul S. Thorner, Rajko Kušec, (unknown), Elı́as Campo, Brunangelo Falini, Alan G. Ramsay, Teresa Marafioti, H. Stein, P. M. Kluin, Karen Pulford, D Y Mason	4
19	In-Situ Hybridization—Principles and Practice, 2nd ed 1999 ·Journal of Clinical Pathology ·Alan G. Ramsay	0
20	Therapy of human B‐cell lymphoma bearing scid mice is more effective with anti‐CD19‐and anti‐CD38‐saporin immunotoxins used in combination than with either immunotoxin used alone 1995 ·International Journal of Cancer ·David J. Flavell, Deborah A. Boehm, (unknown), (unknown), Alan G. Ramsay, (unknown)	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact